loadpatents
Patent applications and USPTO patent grants for Algiax Pharmaceuticals GmbH.The latest application filed is for "treatment of cognitive disorders".
Patent | Date |
---|---|
2-cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives Grant 10,472,324 - Hasse , et al. Nov | 2019-11-12 |
Treatment Of Cognitive Disorders App 20170119775 - Koopmans; Guido ;   et al. | 2017-05-04 |
2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamide Derivatives App 20170088513 - Hasse; Birgit ;   et al. | 2017-03-30 |
Use of malononitrilamides in neuropathic pain Grant 9,468,615 - Hasse , et al. October 18, 2 | 2016-10-18 |
Novel Use For Imidazotriazinones App 20160022688 - Koopmans; Guido ;   et al. | 2016-01-28 |
Use of leflunomide and malononitrilamides Grant 8,957,098 - Koopmans , et al. February 17, 2 | 2015-02-17 |
Novel Use Of Benzofuranylsulfonates App 20140057978 - Koopmans; Guido ;   et al. | 2014-02-27 |
Novel Use For Imidazotriazinones App 20140038967 - Koopmans; Guido ;   et al. | 2014-02-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.